Arvida Group Limited — Annual Report 2026 (year ended 31 March)
Arvida Group Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
New Zealand company portfolio; financial year ended 31 March 2026
Medium confidence
verified
Primary-source research review
Evidence boundary: Commercial primary issuer evidence for FY2026, with all 42 original pages inspected. Catalogue publication day follows issuer archive 27 May; financial approval/audit 27 May and exchange publication 28 May are distinct, with first availability not independently determined. Audited financial statements cover pp. 9–34; portfolio/feedback/development narrative and underlying EBITDA have separate assurance limits. NPS timing, sample, response rate and care/living breakdown are absent. No numeric EBITDA reconciliation is established here. Mixed units/beds, rounded people counts and an equity-accounted JV are not interchangeable. Valuation sensitivities and assumptions about future subsidies are modelling inputs, not enacted policy, predictions or resident liabilities. Future projects and conditional Cascades sale remain proposals at this edition’s date. Financial notes retain some legacy agency terminology and must not be used as a current referral pathway or legal guidance; ORA accounting descriptions are not individual refund guarantees. Original PDF/name/category and June 2026 access history preserved; both issuer-CDN and NZX original bytes verified 10 October 2026. No independent clinical certification, current access guarantee or investment recommendation.
Short Answer
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Why it matters
Develop provider-specific questions about care capacity, feedback methodology, staffing, contracts, valuation assumptions and future delivery; use financial notes to distinguish accounting descriptions from individual legal rights.
Key Points
- •42 physical pages; period 1 April 2025–31 March 2026. Issuer archive date and financial approval/audit: 27 May 2026; exchange publication: 28 May 2026 at 08:32 NZST (pp. 2, 8, 37; primary archive/exchange payload).
- •The company says shareholder-approved reporting concessions explain the reduced annual-report scope. It explicitly excludes audit/review of the remaining narrative; this is not the earlier 138-page FY2024 integrated edition (p. 2).
- •The FY2026 snapshot reports 34 retirement communities, 5,700 combined units/care beds, 6,750 residents and 2,900 team members. These are company portfolio measures with mixed unit types, not nationwide counts (p. 4).
- •The leadership letter reports 55 care suites and 53 premium apartments completed at Bethlehem Shores. Lincoln Plains’ 190 villas/36 suites and Waikanae Beach’s approximately 172 homes/suites are expected development, not operating beds (p. 5).
- •Resident NPS is reported as +42 without survey timing, response count/rate or separate care and independent-living results here; it is not an independently verified clinical-quality measure (p. 5).
- •Audited net profit after tax was $97.276 million versus $100.793 million, with a $124.230 million investment-property fair-value gain. Total revenue was $262.696 million, including $171.982 million care fees/village services (p. 9).
Full Summary & Notes
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Open the full summary for detailed notes and source links.
Arvida’s retained Annual Report 2026 covers 1 April 2025 to 31 March 2026 and contains 42 physical pages. The issuer archive labels it 27 May 2026, matching financial approval and EY’s audit date; NZX published the annual report alongside results at 08:32 NZST on 28 May. Those date kinds are retained separately. Both current issuer-CDN and exchange attachments match the original June 2026 capture byte for byte.
The report is shorter than earlier integrated editions. It explains the shareholder’s use of reporting concessions and primarily supplies financial statements, with a short profile and Chair/CEO letter. The snapshot reports 34 retirement communities, 5,700 combined units and care beds, 6,750 residents and 2,900 team members. These rounded company measures are not a national care-bed or workforce census. The letter reports 55 care suites and 53 premium apartments completed at Bethlehem Shores; Lincoln Plains, Mayfair in Auckland and Waikanae Beach are development programmes with future delivery expectations. Its resident NPS of +42 has no survey date, sample size, response rate or independent-living/care breakdown supplied here.
Audited profit after tax was $97.276 million, down from $100.793 million; it includes a $124.230 million investment-property fair-value gain. Net operating cash flow fell to $107.758 million from $160.798 million and includes ORA receipts and repayments. The company’s $133 million underlying EBITDA is explicitly unaudited non-GAAP. EY’s unmodified financial opinion covers pages 9–34 and excludes the wider narrative.
Use the source to understand period-specific care/village revenue, capital assumptions, ORA accounting and the difference between completed and proposed capacity. It does not establish current staffing, vacancies, certification, resident outcomes, statutory rights or delivered future projects. The separate market release is doc-0195.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
The report brings together a corporate portfolio overview, strategy, resident experience, workforce and environmental initiatives, audited consolidated financial statements and remuneration/governance reporting. Its accounts report a statutory loss despite improved adjusted operating earnings and positive aggregate free cash flow; the existing-operations component of that cash flow remains negative. Restated FY25 values and the note 2 reconciliation are essential for comparisons. Use the company’s dated care occupancy and portfolio figures to frame questions, with mature-site and cross-country boundaries retained. Organisation-wide team members are not clinical staffing FTE; NPS and participation scores lack detailed survey denominators. Testimonials, product roll-outs and training claims are commercial narrative rather than independently evaluated clinical evidence. Future construction, demographic assertions and dividend/funding expectations require separate subsequent verification.
Report-based reconciliation of a June 2026 source brief. Original authored publication date is known only to year 2026; 5 June dates the annual report, not necessarily the brief. Detailed narrative retains historical strategy and June news context while correcting report contradictions; analyst reaction, subsequent bond events and later role/project outcomes are not independently checked in this scoped review.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
Two-page issuer results release linking unaudited underlying EBITDA, mixed care-suite/apartment completions and portfolio growth to the year ended March 2026; should be read with the full financial annual report, doc-0194.